Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Ophthalmic Inflammation and Infection
Published in: Journal of Ophthalmic Inflammation and Infection 4/2012

Open Access 01-12-2012 | Brief Report

Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis

Authors: Mridula William, Sepideh Faez, George N. Papaliodis, Ann-Marie Lobo

Published in: Journal of Ophthalmic Inflammation and Infection | Issue 4/2012

Login to get access

Excerpt

Juvenile idiopathic arthritis (JIA)-associated uveitis is a potentially blinding disease and accounts for up to 75 % of all pediatric anterior uveitis cases in many tertiary care referral centers [1]. Inability to control ocular inflammation in pediatric uveitis can lead to complications such as cataracts, macular edema, band keratopathy, and glaucoma leading to vision loss [1]. …
Literature
1.
Foster CS (2003) Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol 14(6):395–398PubMedCrossRef
2.
Foeldvari I, Nielsen S, Kummerle-Deschner J, Espada G, Horneff G, Bica B, Olivieri AN, Wierk A, Saurenmann RK (2007) Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol 34(5):1146–1150PubMed
3.
Kay J, Rahman MU (2010) Golimumab: a novel human anti-TNF-alpha monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. Core Evid 4:159–170PubMedPubMedCentral
4.
Jabs DA, Nussenblatt RB, Rosenbaum JT, G. Standardization of Uveitis Nomenclature Working (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140(3):509–516PubMedCrossRef
5.
Cordero-Coma M, Salom D, Diaz-Llopis M, Lopez-Prats MJ, Calleja S (1892) (2011) Golimumab for uveitis. Ophthalmology 118(9):e3–e4
6.
Schoels M, Aletaha D, Smolen JS, Wong JB (2012) Comparative effectiveness and safety of biological treatment options after tumour necrosis factor alpha inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis. Ann Rheum Dis
7.
Ash Z, Emery P (2011) Golimumab—a new tool in the armoury against inflammatory arthritis. Ann Med 43(2):133–141PubMedCrossRef
Metadata
Title
Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis
Authors
Mridula William
Sepideh Faez
George N. Papaliodis
Ann-Marie Lobo
Publication date
01-12-2012
Publisher
Springer Berlin Heidelberg
Published in
Journal of Ophthalmic Inflammation and Infection / Issue 4/2012
Electronic ISSN: 1869-5760
DOI
https://doi.org/10.1007/s12348-012-0081-y

Other articles of this Issue 4/2012

Journal of Ophthalmic Inflammation and Infection 4/2012 Go to the issue

Brief Report

Probable Vogt–Koyanagi–Harada disease with initial unilateral ocular manifestation in a hepatitis C carrier

Brief Report

A case report of cryptococcal meningoencephalitis presenting as uveitis

Original Research

Characterization of serous retinal detachments in uveitis patients with optical coherence tomography

Brief Report

Infectious crystalline keratopathy associated with Klebsiella oxytoca

Original Research

Indocyanine green angiography findings in patients with nonfamilial amyloidosis

Brief Report

Nontuberculous mycobacterial infection after frontalis sling surgery using silicone rod